Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

LifeMD Q2 2024 Adj. EPS $0.06 Beats $(0.12) Estimate, Sales $50.662M Beat $48.251M Estimate

Author: Benzinga Newsdesk | August 07, 2024 05:41pm
LifeMD (NASDAQ:LFMD) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $(0.12) by 150 percent. The company reported quarterly sales of $50.662 million which beat the analyst consensus estimate of $48.251 million by 5.00 percent. This is a 40.94 percent increase over sales of $35.947 million the same period last year.

Posted In: LFMD


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist